Cargando…
Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways
The study of genetic factors regulating breast cancer malignancy is a top priority to mitigate the morbidity and mortality associated with this disease. One of these factors, Pax-5, modulates cancer aggressiveness through the regulation of various components of the epithelial to mesenchymal transiti...
Autores principales: | Benzina, Sami, Harquail, Jason, Guerrette, Roxann, O'Brien, Pierre, Jean, Stéphanie, Crapoulet, Nicolas, Robichaud, Gilles A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219892/ https://www.ncbi.nlm.nih.gov/pubmed/28070224 http://dx.doi.org/10.7150/jca.15200 |
Ejemplares similares
-
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes
por: Benzina, Sami, et al.
Publicado: (2017) -
Pax-5 Protein Expression Is Regulated by Transcriptional 3′UTR Editing
por: Beauregard, Annie-Pier, et al.
Publicado: (2021) -
Pathogenic variants carrier screening in New Brunswick: Acadians reveal high carrier frequency for multiple genetic disorders
por: Robichaud, Philippe Pierre, et al.
Publicado: (2022) -
The Pleiotropy of PAX5 Gene Products and Function
por: Nasri Nasrabadi, Parinaz, et al.
Publicado: (2022) -
EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex
por: Bullerwell, Charles E., et al.
Publicado: (2021)